Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117300) titled 'A multicenter, real-world study of the efficacy of domestic paliperidone palmitate injection and its impact on family burden' on Jan. 22.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Hospital of Hebei Medical University
Condition:
Schizophrenia
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-02-20
Target Sample Size: Observation group:2000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=306364
Disclaimer: Curated by HT Syndication....